MedPath

ew method of levothyroxine dose estimation in primary Hypothyroidism

Not Applicable
Conditions
Health Condition 1: E038- Other specified hypothyroidism
Registration Number
CTRI/2021/07/034565
Lead Sponsor
Principal Investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age above 18 years and <60 years,

2.Newly diagnosed with primary hypothyroidism (overt and subclinical hypothyroidism)

3.Treatment-na�¯ve (not started on thyroid hormone treatment)

Exclusion Criteria

1.Pregnancy,

2.Central hypothyroidism,

3.Within two years of post-radiotherapy or radioiodine ablation,

4.Post total thyroidectomy cases,

5.Major co-morbidities,

6.Co-prescription of treatment known to affect thyroid hormone metabolism.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Euthyroidism at follow up <br/ ><br>We expect around 60 percent of the participants will achieve euthyroidism at first visit based on calculated doseTimepoint: follow up will be at 6-12 weeks after starting dose and each dose adjustment
Secondary Outcome Measures
NameTimeMethod
To estmate the incidence of Iatrogenic thyrotoxicosis in both armsTimepoint: At the 1st follow-up between 4-8 weeks of starting levothyroxine
© Copyright 2025. All Rights Reserved by MedPath